Obesity dilemma in the global burden of cardiovascular diseases

International Journal of Clinical Practice

Volumn 68, Issue 2, 2014, Pages 173-179

  Boban, M ^a   Persic, V ^a   Jovanovic, Z ^a   Brozina, A ^a   Miletic, B ^a   Rotim, A ^a   Drinkovic, N ^b   Manola, S ^c   Laskarin, G ^a   Boban, L ^d  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KBC Zagreb   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d Croatia   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; GLUCOSE INTOLERANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REHABILITATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NUTRITIONAL ASSESSMENT; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SYSTOLE; VALVULAR HEART DISEASE; COHORT ANALYSIS; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VALVE DISEASES; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEART VALVE DISEASES; HUMANS; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OBESITY; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84893638796     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12254     Document Type: Article

References (30)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i-xii, 1-253.
2. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB,. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-72.
3. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH,. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327: 1350-5.
4. Douketis JD, Sharma AM,. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction. Semin Vasc Med 2005; 5: 25-33.
5. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA 1999; 282: 1547-53.
6. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG,. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 2004; 28 (Suppl. 4): S58-65.
7. Woodiwiss AJ, Libhaber CD, Majane OH, Libhaber E, Maseko M, Norton GR,. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am J Hypertens 2008; 21: 1144-51.
8. Rider OJ, Cox P, Tyler D, Clarke K, Neubauer S,. Myocardial substrate metabolism in obesity. Int J Obes 2013; 37: 972-9.
9. Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH,. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110: 3081-7.
10. Todd Miller M, Lavie CJ, White CJ,. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr 2008; 3: 162-7.
11. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS,. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-8.
12. Dublin S, French B, Glazer NL, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 2006; 166: 2322-8.
13. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U,. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16: 121-37.
14. Casas-Vara A, Santolaria F, Fernandez-Bereciartua A, Gonzalez-Reimers E, Garcia-Ochoa A, Martinez-Riera A,. The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition 2012; 28: 616-22.
15. Kastorini CM, Panagiotakos DB,. The obesity paradox: methodological considerations based on epidemiological and clinical evidence-New insights. Maturitas 2012; 72: 220-4.
16. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z,. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003; 22: 321-36.
17. Mathus-Vliegen EM,. Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline. Obes Facts 2012; 5: 460-83.
18. Milanovic SM, Uhernik AI, Fister K, Mihel S, Kovac A, Ivankovic D,. Five-year cumulative incidence of obesity in adults in Croatia: the CroHort study. Coll Antropol 2012; 36 (Suppl. 1): 71-6.
19. Vrazic H, Sikic J, Lucijanic T, et al. The prevalence of overweight and obesity among Croatian hospitalized coronary heart disease patients. Coll Antropol 2012; 36 (Suppl. 1): 211-6.
20. Cubeddu LX, Hoffmann IS,. Metabolic syndrome: an all or none or a continuum load of risk? Metab Syndr Relat Disord 2012; 10: 14-9.
21. Lavie CJ, De Schutter A, Patel DA, Romero-Corral A, Artham SM, Milani RV,. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox". J Am Coll Cardiol 2012; 60: 1374-80.
22. Wong M, Staszewsky L, Latini R, et al. Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data. J Am Coll Cardiol 2004; 43: 2022-7.
23. Angeras O, Albertsson P, Karason K, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J 2013; 34: 345-53.
24. Lavie CJ, Milani RV, Patel D, Artham SM, Ventura HO,. Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function. Postgrad Med 2009; 121: 119-25.
25. Chrysant SG,. A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention. Hippokratia 2011; 15: 7-11.
26. Douketis JD, Macie C, Thabane L, Williamson DF,. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes 2005; 29: 1153-67.
27. Smith SC Jr., Blair SN, Bonow RO, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2001; 38: 1581-3.
28. Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil Prev 2007; 27: 121-9.
29. Florez H, Castillo-Florez S,. Beyond the obesity paradox in diabetes: fitness, fatness, and mortality. JAMA 2012; 308: 619-20.
30. Avenell A, Brown TJ, McGee MA, et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet 2004; 17: 317-35.